| scholarly article | Q13442814 |
| P50 | author | Andreu Ferrero | Q82937165 |
| Antoni Bayes-Genis | Q43187656 | ||
| P2093 | author name string | Jordi Ordoñez-Llanos | |
| Juan Cinca | |||
| Eulàlia Roig | |||
| Mariana Noguero | |||
| Josefina Mora | |||
| Sònia Mirabet | |||
| Ana B Méndez | |||
| Teresa Mir | |||
| P2860 | cites work | G Protein-Coupled Receptor Kinase 2 in Patients With Acute Myocardial Infarction | Q58651682 |
| Coronary Heart Disease Risk Factors and Mortality | Q58811851 | ||
| Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients | Q60619537 | ||
| Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids | Q73721270 | ||
| Prognostic value of serum cytokines in patients with congestive heart failure | Q73784678 | ||
| CA125 production by the peritoneum: in-vitro and in-vivo studies | Q73834486 | ||
| Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid | Q79342913 | ||
| Serum carbohydrate antigen 125 levels in advanced heart failure: relation to B-type natriuretic peptide and left atrial volume | Q81332706 | ||
| Relationship between cytokines and tumour markers in patients with chronic heart failure | Q81534888 | ||
| Biomarkers of risk stratification in congestive heart failure: North American view | Q84239890 | ||
| Use of B-type natriuretic peptide in critically ill patients | Q84239915 | ||
| Propensity score methods for creating covariate balance in observational studies | Q27000423 | ||
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure. | Q30542622 | ||
| More than 15 years of CA 125: what is known about the antigen, its structure and its function. | Q33608460 | ||
| Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure | Q34139611 | ||
| Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath | Q34347905 | ||
| Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). | Q34557005 | ||
| ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the | Q34640762 | ||
| Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. | Q34777591 | ||
| Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study | Q35705092 | ||
| Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication | Q35820045 | ||
| Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? | Q35954702 | ||
| The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects | Q37163361 | ||
| Tumour biomarkers in heart failure: is there a role for CA-125? | Q37869633 | ||
| Long-term prognostic value of CA 125 serum levels in mild to moderate heart failure patients | Q39672291 | ||
| N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. | Q40479579 | ||
| Biomarkers for coronary artery disease: mission impossible? | Q43021452 | ||
| B-type natriuretic peptide predicts sudden death in patients with chronic heart failure | Q43703424 | ||
| Prognostic value of cytokines and neurohormones in severe heart failure | Q43997027 | ||
| Divergent trends in survival and readmission following a hospitalization for heart failure in the Veterans Affairs health care system 2002 to 2006. | Q44793228 | ||
| The heart failure epidemic: exactly how big is it? | Q44815350 | ||
| Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure | Q44885046 | ||
| Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database | Q46874074 | ||
| Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis | Q47886116 | ||
| N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction | Q48030167 | ||
| Plasma microRNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure | Q48173779 | ||
| Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure | Q48186504 | ||
| The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study | Q48935479 | ||
| CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure. | Q51870022 | ||
| Estrategias para la elaboración de modelos estadísticos de regresión | Q57259838 | ||
| A comparison of echocardiographic measures of diastolic function for predicting all-cause mortality in a predominantly male population | Q58394319 | ||
| P433 | issue | 4 | |
| P921 | main subject | heart failure | Q181754 |
| P304 | page(s) | 205-212 | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | World journal of cardiology | Q27723312 |
| P1476 | title | Prognostic value of increased carbohydrate antigen in patients with heart failure | |
| P478 | volume | 6 |
| Q64981072 | CA125 as a Marker of Heart Failure in the Older Women: Population-Based Analysis. |
| Q48129798 | Cancer antigen-125 and risk of atrial fibrillation: a systematic review and meta-analysis |
| Q40927408 | Cancer antigen-125 levels predict long-term mortality in chronic obstructive pulmonary disease. |
Search more.